
Option Care Health Stock Jumps 34% on $5.8B Buyout Deal
Why is Option Care Health stock up today?
Option Care Health (OPCH) stock jumped about 34% to roughly $31 on Tuesday after CD&R and McKesson agreed to buy it for $32.05 a share, a $5.8 billion deal including debt.
Key numbers
| Offer price per share | $32.05+37% vs Oct 5 close |
|---|---|
| Deal value incl. debt | $5.8B |
| OPCH early trading | ~$31.03+33% to +34% |
| McKesson investment (49%) | $1.4B |
| Oct 5 close before deal | $23.37+3% on day |
What happened
Option Care Health (OPCH) stock jumped about 34% to roughly $31 on Tuesday after CD&R and McKesson agreed to buy it for $32.05 a share, a $5.8 billion deal including debt. That price is 37% above Monday's close of $23.37. CD&R, a private equity firm, would own 51% and drug distributor McKesson 49%, investing about $1.4 billion. Shares had already climbed about 22% after hours Monday when the Financial Times reported the talks. The deal is expected to close in the first half of 2027.
Why it matters
Option Care Health is the largest independent provider of infusion care, where patients get IV medicines at home instead of in a hospital. The sale takes it off the stock market, so shareholders are paid in cash and the stock will stop trading once the deal closes. McKesson, which already supplies drugs to doctors, gets a bigger role in home care and can later buy CD&R's stake. Shareholders and regulators must still approve the deal.
Who this affects
- MarketneutralLow impact
- Option Care shareholders gain; wider market barely affected.
- CompanybullishHigh impact
- Shareholders cash out at $32.05; company goes private in 2027.
- CompetitorsmixedMedium impact
- McKesson gains home-infusion reach; smaller rivals face stiffer competition.
- IndustrybullishMedium impact
- Home-infusion care draws big-money interest, signaling growth appeal.
Option Care Health vs McKesson, Cardinal Health, Cencora
How we got here
Financial Times reports McKesson and CD&R near a $5B-plus deal; shares rise about 22% after hours.
Option Care Health announces definitive agreement at $32.05 per share, about $5.8B including debt.
Shares jump about 34% in early trading to roughly $31.
What to watch
- Option Care shareholder vote and regulatory approvals needed to complete the deal.H1 2027
- Whether McKesson later buys CD&R's 51% stake under the agreed framework.After closing
Educational content only. Not investment advice.
More briefsAll briefs →
Alphabet Stock Rises 1.8% on AI Chip Demand
Alphabet (GOOGL) closed near $299 as Google said nearly 100 customers use its custom TPU AI chips.
Cerebras Stock Jumps 14% After Q3 Revenue Beat
Cerebras (CBRS) guided fourth-quarter sales to $310–330M, well above the $271M analysts expected.

Tetra Tech Stock Jumps 11% After Earnings Beat
Tetra Tech (TTEK) posted a record $4.67B backlog and raised its dividend 11%, though shares closed up 4.8%.